Can Tirzepatide Help with Fatty Liver Disease and NASH?

Conclusion

To wrap up this blog post, it is clear that tirzepatide is a promising new drug that may be great in the future for the treatment of NASH and fatty liver disease. Its ability to reduce liver fat, lower blood glucose levels, and promote weight loss make it an attractive option for patients with these conditions. If you would like to learn more about the benefits of tirzepatide and you are someone with type 2 diabetes or obesity (even without fatty liver disease or NASH), our physicians at Mochi Health can fill you in! We prescribe tirzepatide and many other medications for medication-assisted weight loss in a tele-health format for your convenience. 

‍

References:

1. Hartman ML, Sanyal AJ, Loomba R, et al. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes. Diabetes Care. 2020;43(6):1352-1355. doi:10.2337/dc19-1892

2. Polyzos SA, Goulas A, Papaioannidou P. Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis [published online ahead of print, 2023 Jan 6]. Curr Med Chem. 2023;10.2174/0929867330666230106103202. doi:10.2174/0929867330666230106103202

‍

This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.